11 Patents
- 0 cites
- US122344602025Methods of Treating Decreased Bone Mineral Density with Cluster of Differentiation 109 (CD109) Inhibitors
The Royal Institution For The Advancement Of Learning/mcgill University
0 cites - US122153222025Treatment of Liver Disease with Mitochondrial Glycerol-3-phosphate Acyltransferase (GPAM) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US121230012024Methods of Treating Liver Diseases with Phosphodiesterase 3B (PDE3B) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US120496702024Proprotein Convertase Subtilisin/kexin Type 1 (PCSK1) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US120182592024Treatment of Liver Diseases with Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US119577042024Methods of Treating Metabolic Disorders and Cardiovascular Disease with Inhibin Subunit Beta E (INHBE) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US119396352024Treatment of Obesity in Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR)
Regeneron Pharmaceuticals, Inc.
0 cites - US118916072024Methods of Treating Decreased Bone Mineral Density with Cluster of Differentiation 109 (CD109) Inhibitors
The Royal Institution For The Advancement Of Learning/mcgill University
0 cites - US117733932023Treatment of Liver Diseases with Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117594762023Methods of Treating Metabolic Disorders and Cardiovascular Disease with Inhibin Subunit Beta E (INHBE) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites